Investor Type | Firm |
Industries | BioTech • Hardware (& Manufacturing) • CleanTech • HealthTech (& Fitness) • Insurance (& InsurTech) • Medical Devices (& Hospital Services) • Robotics • DeepTech |
Stages | Series B, Series A |
Investment Range | $500,000 - $5,000,000 |
Investment Sweet Spot | $2,000,000 |
Akilia Partners is an investment fund that focuses on providing capital to innovative companies operating within a diverse range of industries including BioTech, Hardware and Manufacturing, CleanTech, HealthTech and Fitness, Insurance and InsurTech, Medical Devices and Hospital Services, Robotics, and DeepTech. They are particularly interested in companies that are at the Series A and Series B stages, targeting investment opportunities that align with their expertise in these sectors. Akilia Partners' investment strategy is characterized by its substantial financial commitment, with a minimum investment threshold of $500,000, and the ability to invest up to $5,000,000, signaling a hands-on approach to fostering growth and scale in their portfolio companies. Their sweet spot for investment is around $2,000,000, indicating a preference for deals where they can make a significant impact without overextending their commitment relative to the size of the fund. As specialists in working with growth-stage companies, Akilia Partners likely brings not only capital but also strategic guidance, network access, and operational expertise to the table, leveraging their resources to support companies through critical growth phases. The exact details of their value-add services, team expertise, past investments, and success stories are detailed on their website, which provides comprehensive insight into their investment philosophy and operational processes.